No Data
No Data
Express News | Shares of Weight Loss Stocks Are Trading Lower, Possibly on Continued Weakness Following Recent Weight Loss Data From Roche, Which Could Cause Competition Concerns for Companies in the Space
Novo Nordisk on Pace for Largest Percent Decrease Since February 2023 -- Data Talk
Novo Nordisk A/S Sponsored ADR Class B (NVO) is currently at $129.23, down $6.19 or 4.57% --Would be lowest close since May 10, 2024, when it closed at $128.42 --On pace for largest percent decrease
Eli Lilly's Stock Plunges as Investors Eye Obesity-drug Competition
By Eleanor Laise 'Vast' weight-loss drug pipeline keeps Lilly in a strong position as field gets crowded, analysts say Eli Lilly & Co.'s stock was on pace for its worst day in about three years
Eli Lilly, Novo Extend Muti-day Decline in Rare Selloff
European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday
European equities traded in the US as American depositary receipts were moving moderately lower late Thursday morning, declining 0.72% to 1,423.26 on the S&P Europe Select ADR Index.From continental
Top Gap Ups and Downs on Wednesday: TSM, NVO, ASML and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
No Data